Institutional investors purchased a net $3.9 million shares of MEIP during the quarter ended December 2012 and now own 38.10% of the total shares outstanding. This is a greater percentage than is typical for companies in the Pharmaceuticals: Other industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FIDELITY MANAGEMENT & RESEARCH C... Bought 1.9 Million shares of MEI Pharma Inc
GREAT POINT PARTNERS LLC Bought 1.3 Million shares of MEI Pharma Inc
OPPENHEIMERFUNDS, INC. Bought 1.0 Million shares of MEI Pharma Inc